ClinicoEconomics and Outcomes Research最新文献

{"title":"Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test from a US Societal Perspective","authors":"Vladislav Berdunov, G. Cuyun Carter, E. Laws, Roger Luo, Christy Russell, Sara Campbell, Yara Abdou, Jeremy Force","doi":"10.2147/ceor.s449711","DOIUrl":"https://doi.org/10.2147/ceor.s449711","url":null,"abstract":"","PeriodicalId":504030,"journal":{"name":"ClinicoEconomics and Outcomes Research","volume":"60 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141275748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: An Integrative Literature Review","authors":"Grace Fox, Mark Bernauer, Jennifer Stephens, Bianca Jackson, Joshua Roth, A. Shelbaya","doi":"10.2147/ceor.s445697","DOIUrl":"https://doi.org/10.2147/ceor.s445697","url":null,"abstract":"Purpose: While the value of individual biosimilars is evident, little is known about the value of a biosimilar portfolio beyond the cost savings between biosimilars and originators. Stakeholders may consider the value of a manufacturer’s biosimilar portfolio, especially when negotiating portfolio-based contracts or other rebate programs. However, little is known about what other types of value, in addition to financial benefits, decision-makers perceive regarding a manufacturer with a biosimilar portfolio compared to those without one. The objective of this integrative literature review was to describe a conceptual framework consisting of themes that may help define the value of a biosimilar portfolio. Methods: An integrative literature review was conducted using Excerpta Medica Database (Embase) and Medical Literature Analysis and Retrieval System Online (MEDLINE). Grey literature searches of search engines, journals not indexed in Embase or MEDLINE, healthcare payers, health technology assessment bodies, value frameworks, and non-pharmaceutical industry analogs were also conducted. Eligible studies reported on the value of a biosimilar portfolio in decision-making by stakeholders. Apart from the literature, insights were gained from clinical experience and observation. Results: No studies investigating biosimilar portfolio value were identified; however, several themes were identified that may help define the value of a biosimilar portfolio: Manufacturing; procurement, inventory, and storage; administration; education; and transaction costs. Several non-pharmaceutical industry analogs were identified: Product line length and single-supplier versus multiple-supplier procurement. Several themes were identified through other sources: Science credibility and research. Based on these themes, we developed a conceptual framework for biosimilar portfolio value. Conclusion: To our knowledge, this is the first study to systematically assess and create a framework for biosimilar portfolio value. The conceptual framework described here could be tested to quantify the clinical and economic value associated with a biosimilar portfolio.","PeriodicalId":504030,"journal":{"name":"ClinicoEconomics and Outcomes Research","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141023643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies","authors":"Vivek Reddy, Yue Zhong, A. McGovern, Stacey Amorosi, Meghan Gavaghan, Deanna Hertz, Kaywei Low, Scott Freeman, David Holmes Jr","doi":"10.2147/ceor.s440556","DOIUrl":"https://doi.org/10.2147/ceor.s440556","url":null,"abstract":"","PeriodicalId":504030,"journal":{"name":"ClinicoEconomics and Outcomes Research","volume":"48 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139825072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies","authors":"Vivek Reddy, Yue Zhong, A. McGovern, Stacey Amorosi, Meghan Gavaghan, Deanna Hertz, Kaywei Low, Scott Freeman, David Holmes Jr","doi":"10.2147/ceor.s440556","DOIUrl":"https://doi.org/10.2147/ceor.s440556","url":null,"abstract":"","PeriodicalId":504030,"journal":{"name":"ClinicoEconomics and Outcomes Research","volume":"18 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139885182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Cost-Effectiveness of Dolutegravir in Combination with Tenofovir and Lamivudine for HIV Therapy: A Systematic Review","authors":"Santi Aprilianti, Auliasari M Utami, A. Suwantika, N. Zakiyah, Vanji Azis","doi":"10.2147/ceor.s439725","DOIUrl":"https://doi.org/10.2147/ceor.s439725","url":null,"abstract":"","PeriodicalId":504030,"journal":{"name":"ClinicoEconomics and Outcomes Research","volume":"50 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139633841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Methods used to account for caregivers’ sex and gender within studies examining the financial burden of caregivers of children and adolescents : Results from a scoping review","authors":"Jason Guertin, M. Gilbert-Ouimet, Michèle Dugas, Valérie Carnovale, Laura Jalbert, Olha Svyntozelska, Juliette Demers, Léonie Matteau, Frédéric Bergéron, Annie LeBlanc","doi":"10.2147/ceor.s443077","DOIUrl":"https://doi.org/10.2147/ceor.s443077","url":null,"abstract":"","PeriodicalId":504030,"journal":{"name":"ClinicoEconomics and Outcomes Research","volume":"7 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139638076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}